» Articles » PMID: 38340968

Keratinocyte Integrin α3β1 Induces Expression of the Macrophage Stimulating Factor, CSF-1, Through a YAP/TEAD-dependent Mechanism

Overview
Journal Matrix Biol
Publisher Elsevier
Date 2024 Feb 10
PMID 38340968
Authors
Affiliations
Soon will be listed here.
Abstract

The development of wound therapy targeting integrins is hampered by inadequate understanding of integrin function in cutaneous wound healing and the wound microenvironment. Following cutaneous injury, keratinocytes migrate to restore the skin barrier, and macrophages aid in debris clearance. Thus, both keratinocytes and macrophages are critical to the coordination of tissue repair. Keratinocyte integrins have been shown to participate in this coordinated effort by regulating secreted factors, some of which crosstalk to distinct cells in the wound microenvironment. Epidermal integrin α3β1 is a receptor for laminin-332 in the cutaneous basement membrane. Here we show that wounds deficient in epidermal α3β1 express less epidermal-derived macrophage colony-stimulating factor 1 (CSF-1), the primary macrophage-stimulating growth factor. α3β1-deficient wounds also have fewer wound-proximal macrophages, suggesting that keratinocyte α3β1 may stimulate wound macrophages through the regulation of CSF-1. Indeed, using a set of immortalized keratinocytes, we demonstrate that keratinocyte-derived CSF-1 supports macrophage growth, and that α3β1 regulates Csf1 expression through Src-dependent stimulation of Yes-associated protein (YAP)-Transcriptional enhanced associate domain (TEAD)-mediated transcription. Consistently, α3β1-deficient wounds in vivo display a substantially reduced number of keratinocytes with YAP-positive nuclei. Overall, our current findings identify a novel role for epidermal integrin α3β1 in regulating the cutaneous wound microenvironment by mediating paracrine crosstalk from keratinocytes to wound macrophages, implicating α3β1 as a potential target of wound therapy.

Citing Articles

YAP/TAZ Signalling Controls Epidermal Keratinocyte Fate.

Pankratova M, Riabinin A, Butova E, Selivanovskiy A, Morgun E, Ulianov S Int J Mol Sci. 2024; 25(23).

PMID: 39684613 PMC: 11641583. DOI: 10.3390/ijms252312903.


The epidermal integrin-mediated secretome regulates the skin microenvironment during tumorigenesis and repair.

Longmate W Matrix Biol. 2024; 134:175-183.

PMID: 39491760 PMC: 11585437. DOI: 10.1016/j.matbio.2024.11.002.


Keratinocyte Integrin α3β1 Promotes Efficient Healing of Wound Epidermis.

Dhulipalla S, Duarte G, Wu L, DiPersio M, Lamar J, DiPersio C JID Innov. 2024; 5(1):100310.

PMID: 39385750 PMC: 11459640. DOI: 10.1016/j.xjidi.2024.100310.


Roles for epithelial integrin α3β1 in regulation of the microenvironment during normal and pathological tissue remodeling.

Miskin R, DiPersio C Am J Physiol Cell Physiol. 2024; 326(5):C1308-C1319.

PMID: 38497112 PMC: 11371326. DOI: 10.1152/ajpcell.00128.2024.

References
1.
Dey A, Varelas X, Guan K . Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. Nat Rev Drug Discov. 2020; 19(7):480-494. PMC: 7880238. DOI: 10.1038/s41573-020-0070-z. View

2.
Dvorak H . Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986; 315(26):1650-9. DOI: 10.1056/NEJM198612253152606. View

3.
Longmate W, Varney S, Power D, Miskin R, Anderson K, DeFreest L . Integrin α3β1 on Tumor Keratinocytes Is Essential to Maintain Tumor Growth and Promotes a Tumor-Supportive Keratinocyte Secretome. J Invest Dermatol. 2020; 141(1):142-151.e6. PMC: 7680721. DOI: 10.1016/j.jid.2020.05.080. View

4.
Walko G, Woodhouse S, Pisco A, Rognoni E, Liakath-Ali K, Lichtenberger B . A genome-wide screen identifies YAP/WBP2 interplay conferring growth advantage on human epidermal stem cells. Nat Commun. 2017; 8:14744. PMC: 5376649. DOI: 10.1038/ncomms14744. View

5.
Lamar J, Xiao Y, Norton E, Jiang Z, Gerhard G, Kooner S . SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis. J Biol Chem. 2018; 294(7):2302-2317. PMC: 6378979. DOI: 10.1074/jbc.RA118.004364. View